235 related articles for article (PubMed ID: 8553553)
1. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.
Mitra D; Sikder SK; Laurence J
Virology; 1995 Dec; 214(2):512-21. PubMed ID: 8553553
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1.
Soudeyns H; Geleziunas R; Shyamala G; Hiscott J; Wainberg MA
Virology; 1993 Jun; 194(2):758-68. PubMed ID: 7684876
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
5. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements.
Khare S; Kumar KU; Tang SC; Pater MM; Pater A
J Med Virol; 1996 Nov; 50(3):254-62. PubMed ID: 8923291
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
Zhang JL; Sharma PL; Crumpacker CS
Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HIV-1 gene expression by NF-IL6.
Tesmer VM; Bina M
J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
Schuetz JD; Schuetz EG; Thottassery JV; Guzelian PS; Strom S; Sun D
Mol Pharmacol; 1996 Jan; 49(1):63-72. PubMed ID: 8569713
[TBL] [Abstract][Full Text] [Related]
10. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
Yurochko AD; Huong SM; Huang ES
J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
[TBL] [Abstract][Full Text] [Related]
11. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
Cron RQ; Bartz SR; Clausell A; Bort SJ; Klebanoff SJ; Lewis DB
Clin Immunol; 2000 Mar; 94(3):179-91. PubMed ID: 10692237
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid stimulates primate but inhibits rodent alpha-fetoprotein gene promoter.
Nakabayashi H; Koyama Y; Sakai M; Li HM; Wong NC; Nishi S
Biochem Biophys Res Commun; 2001 Sep; 287(1):160-72. PubMed ID: 11549270
[TBL] [Abstract][Full Text] [Related]
13. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element.
Flick MB; Sapi E; Kacinski BM
J Cell Biochem; 2002; 85(1):10-23. PubMed ID: 11891846
[TBL] [Abstract][Full Text] [Related]
15. The human immunodeficiency virus long terminal repeat contains sequences showing partial homology to glucocorticoid responsive elements.
Katsanakis CD; Sekeris CE; Spandidos DA
Anticancer Res; 1991; 11(1):381-3. PubMed ID: 2018375
[TBL] [Abstract][Full Text] [Related]
16. Regulation of A-raf expression.
Lee JE; Beck TW; Wojnowski L; Rapp UR
Oncogene; 1996 Apr; 12(8):1669-77. PubMed ID: 8622887
[TBL] [Abstract][Full Text] [Related]
17. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
18. A natural sequence consisting of overlapping glucocorticoid-responsive elements mediates glucocorticoid, but not androgen, regulation of gene expression.
Massaad C; Garlatti M; Wilson EM; Cadepond F; Barouki R
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):123-9. PubMed ID: 10926835
[TBL] [Abstract][Full Text] [Related]
19. Autoregulation of human relaxin-2 gene expression critically involves relaxin and glucocorticoid receptor binding to glucocorticoid response half-sites in the relaxin-2 promoter.
Dschietzig T; Bartsch C; Wessler S; Baumann G; Stangl K
Regul Pept; 2009 Jun; 155(1-3):163-73. PubMed ID: 19289144
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology.
Kino T; Kopp JB; Chrousos GP
J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):283-90. PubMed ID: 11282284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
